Hunting ( ($GB:HTG) ) just unveiled an update. Hunting PLC has executed a share buyback program, purchasing 129,850 of its ordinary shares at an ...

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...

Dole plc (NYSE: DOLE) ("Dole" or the "Company") today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $100 million of its ...

In a statement, Centessa Pharmaceuticals plc (NASDAQ:CNTA) said it plans to issue more than 11.6 million new American ...

Despite a revenue dip, Endava PLC (DAVA) focuses on AI-driven growth and strategic partnerships to enhance future performance ...

Africa’s economic growth is hinging on creating 1 billion jobs by the end of the century. Where will it find them?

Announced Encouraging Data on both NUC-7738 and NUC-3373 Initial Data from the Expansion Study of NUC-7738 Expected in Q4 2025 with Final Data Expected in 2026 Compliant with All Nasdaq Continued ...

Celebrating exceptional, community-wide excellence, based on rigorous evaluation and selection LONDON, Nov. 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading ...

The Board of Directors (‘Board’) hereby reports to Brait’s shareholders (‘Shareholders’) on the unaudited results for the six months ended 30 Sept ...

Entered into broad strategic collaboration with Eli Lilly and Company (“Lilly”) in the area of ophthalmology, granting Lilly worldwide exclusive rights to the Company’s AAV-AIPL1 program for treatment ...

Alkermes' alixorexton met key goals in a phase 2 study for narcolepsy type 2, showing significant improvements in wakefulness and sleepiness scores.

Baird 55th Annual Global Industrial Conference November 12, 2025 3:55 PM ESTCompany ParticipantsJohn Stone - President, CEO ...